Market Survey on Gene Editing Tools Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Gene Editing Tools Market including Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9), Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), Viral Systems, and Transposon Systems Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
[264 Pages Report] Sales in the global Gene Editing Tools Market are slated to top US$ 481.3 Mn in 2022. Expanding at a healthy 18.8% CAGR, the market size is projected to total US$ 1.6 Bn by 2029.
The high demand for synthetic genes in various biotechnology domains and the rising implementation of CRISPR DNA editing technology are likely to drive the sales in this market. The rapid development of cutting-edge diagnostic tools to prevent the adverse effects of the COVID-19 pandemic also is anticipated to spur the market in the near future.
The surging applications of genome engineering tools is estimated to intensify the competition between various market players worldwide. Gene editing tools manufacturers are currently focusing on the development of highly adaptable CRISPR editing tools to provide accurate, relatively cost-effective and faster results.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
18.36%
H1, 2022 Projected
18.84%
H1, 2022 Outlook
17.74%
BPS Change - H1, 2022 (O) – H1, 2022 (P)
(-) 110 ↓
BPS Change – H1, 2022 (O) – H1, 2021
(-) 62 ↓
The comparative analysis and market growth rate of global gene editing tools market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 110 BPS, and, a negative BPS growth is expected in H1-2022 over H1- 2021 duration with 62 Basis Point Share (BPS).
The reduction in the BPS values is associated with the Low editing efficiency and potential toxicity of the currently available delivery systems in gene editing processes. This has found relevance in CRISPR technologies, and is hence a limiting factor for BPS growth.
Conversely, the development of flexible genome editing technologies, and the completion of the Human Genome Project will promote the growth of the overall gene editing tools market, owed to the wide applicability in disease therapeutics, genetic engineering, and basic biomedical research.
The market is highly influenced by the regulatory approvals, ethical guidelines, and innovation factors under the impact of macro and industry factors. The market is subject to developments like, acquisitions and collaborations, and new product development using novel patented technologies. The key developments in the market include the establishment of CRISPR technology, and Retron Library Recombineering (RLR).
2014-2021 Gene Editing Tools Market Outlook in Comparison to 2022-2029 Growth Forecast
The gene editing tools market is expected to register 18.8% CAGR between 2022 and 2029, up from 16.2% CAGR recorded during 2014-2021, predicts Future Market Insights.
The outbreak of the COVID-19 pandemic has resulted in the rapid development of highly effective genome engineering tools to detect genetic variations in the population of viral strains. The U.S. Food and Drug Administration (FDA), issued the ‘Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests’ in February 2021 to deliver recommendations and policies on investigating the potential impact of future and emerging viral mutations of SARS-CoV-2.
Similarly, in March 2021, a team of scientists at the Nanyang Technological University, Singapore, developed a diagnostic test for detecting the virus that causes COVID-19 even after it undergoes mutations. The test is called VaNGuard and it makes use of CRISPR. In a clinical setting, it can be used on crude patient samples without the requirement of RNA purification.
In May 2020, researchers at the Broad Institute of MIT and Harvard have also unveiled a protocol for utilizing the CRISPR-based Specific High Sensitivity Enzymatic Reporter Unlocking (SHERLOCK) technique to detect COVID-19. This novel technique uses synthetic COVID-19 virus RNA fragments for the detection of the COVID-19 target sequences. It can discover these sequences in a range between 20 and 200 aM. Thus, the ongoing development of various CRISPR editing tools by research and educational institutions is likely to propel the market.
How is the Development of New Genome Editing Techniques Affecting the Market Growth?
The consistent technological advancement in the field of genome engineering tools is projected to drive the market over the forthcoming years. Several biotechnology companies are striving to launch remarkably powerful, precise, easy-to-use, and affordable genome editing techniques to transform the biological research domain.
In April 2021, for instance, six UMass Medical School scientists published a paper in Nature, a prominent research community, to describe the Somatic Cell Genome Editing Consortium’s goals to benchmark and augment the development of effective and safer methods of editing the genomes. The consortium is led by the National Institutes of Health and aims to find out better genome editing tools to edit disease-relevant somatic cells in patients. Spurred by similar other innovations, the demand for these tools is expected to surge in the upcoming years.
The rising awareness regarding the availability of genetically modified animals and crops is set to have a positive impact on the sales of genome editing tools. The increasing focus of various manufacturers on the development of biologics by utilizing synthetic genes and newer biosynthetic pathways in microorganisms is another crucial factor which is expected to propel the market.
Find your sweet spots for generating winning opportunities in this market.
Country-wise Insights
Will the U.S. Gene Editing Tools Market Continue Exhibiting Strong Growth?
“U.S. Market will Pick up Pace as Scientists are Developing New Genome Editing Techniques”
The presence of a robust commercial and research base for the development of advanced therapies is likely to drive the demand for precise genome editing tools in the U.S. The rising number of clinical trials that are being conducted to introduce state-of-the-art stem cell and gene therapies would also propel the demand in the U.S.
In May 2021, researchers at Harvard's Wyss Institute for Biologically Inspired Engineering successfully developed the Retron Library Recombineering (RLR) technique, its new genome editing technique. It would allow scientists to perform millions of genetic experiments simultaneously. Driven by such innovations, the market in the U.S. is set to prosper in the near future.
How is Government Supporting U.K. Gene Editing Tools Market Growth?
“Government is Allowing CRISPR DNA Editing of Crops to Enhance Production”
The increasing research activities in the field of gene editing and the rising need to enhance agricultural production in the U.K. are anticipated to spur the Europe market. The surging prevalence of rare diseases in the country is another significant factor that is projected to aid the growth.
For instance, in January 2022, the U.K. government declared that gene editing will result in the development of climate crisis resistant crops. Research activities related to CRISPR DNA editing of plants in the country will become easier than ever owing to the new norms implemented by the government. These regulations are expected to encourage various development efforts, such as field trials. The rising government support to augment the usage of genome engineering tools is estimated to drive the market in the U.K.
Will the Japan Gene Editing Tools Market Showcase Steady Growth?
“CRISPR Editing Tools are used by Scientists in Japan to Develop Novel Fruits and Vegetables”
The surging focus of many food and agriculture companies operating in Japan on the development of genome edited fruits and vegetables is likely to push the market in East Asia. These companies are striving to unveil new products equipped with beneficial properties to prevent diseases and keep an individual healthy if consumed.
Sanatech Seed launched the first direct consumption genome-edited tomato in Japan in March 2021. Followed by the launch, the Japanese ministries mentioned that the tomatoes will not be regulated as a genetically modified product. These were developed with the help of CRISPR editing tools and contain high levels of an amino acid named gamma-aminobutyric acid (GABA). It would help in lowering the blood pressure and accelerate the feeling of relaxation. The high demand for novel food products from consumers is set to bolster the market in Japan.
Category-wise Insights
Which is the Preferred Product Type in the Gene Editing Tools Market?
“Need to Discover New Treatment Options to Spur Demand for CRISPR Genome Engineering Tools”
Based on product type, the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9) segment is set to lead the gene editing tools market in the upcoming years. This growth is attributable to the increasing usage of CRISPR DNA editing in human-induced pluripotent stem cells (hiPSCs) associated programs for discovering new treatment options of numerous diseases.
This technology is also expected to be utilized for improving the productivity of CHO cell lines. These cell lines are extensively applied in the production of large molecule therapeutics and their high demand is anticipated to propel the sales of CRISPR genome engineering tools.
Which is the Dominant Application in the Gene Editing Tools Market?
“Cell Line Engineering is the Most Preferred Application of Genome Editing Techniques”
In terms of application, the cell line engineering segment is estimated to account for around 41.6% of the gene editing tools market share in 2022, predicts FMI. The rising application of cell line engineering technology in stem cell research is projected to push the segment in the forthcoming years.
These are utilized for induced pluripotent stem cells (iPSCs) that help in modifying the cell genetically, thereby resulting in the rapid development of iPSCs lines. The emergence of cutting-edge genome editing techniques, such as ZFNs, TALENs, and CRISPR/Cas have made cell engineering cost-effective and convenient, which would help in propelling the segment.
Who is the Leading End User in the Gene Editing Tools Market?
“Biotech and Pharma Companies are Collaborating to Develop Precise Genome Editing Tools”
By end user, the biotech and pharma companies segment is likely to dominate in the near future by generating the largest gene editing tools market share in 2029. This growth is attributable to the surging number of research activities happening across the globe among these companies for developing novel therapeutics.
Numerous international pharmaceutical companies are anticipated to join hands with start-up firms to create innovative technologies, which is set to drive the sales of precise genome editing tools. For instance, in April 2021, CANbridge Pharmaceuticals, Inc., which is a renowned biopharmaceutical company, collaborated with LogicBio Therapeutics, Inc., a clinical-stage genetic medicine company.
This partnership would enable the former to get an exclusive license for an investigational in-vivo gene editing technology named LB-001. The technology is based on the latter’s GeneRide platform for the treatment of methylmalonic acidemia (MMA). The development of such products owing to the increasing partnerships among biotech and pharma companies are projected to bolster the demand for precise genome editing techniques.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Competition Landscape
Most of the leading players operating in the global market are focusing on investing in innovative genome engineering tools to cater to the increasing research requirements. Owing to the surging progress in several in vitro cellular and molecular techniques, the research area in genomics is projected to exhibit rapid development. Meanwhile, some of the other key players are undertaking licensing agreements with reputed developers of technology to strengthen their positions in the market.
For instance,
In January 2022, Pfizer, a multinational pharmaceutical and biotechnology corporation based in the U.S., signed a 4-year contract worth US$ 300 million with Massachusetts-based Beam Therapeutics, a pioneer in the development of CRISPR editing tools. Both companies are aiming to work together on 3 programs associated with rare genetic diseases of the central nervous system, muscles, and liver.
In June 2021, Regeneron Pharmaceuticals, a biotechnology company headquartered in New York and Intellia Therapeutics, a developer of biopharmaceuticals based in Cambridge, unveiled a new therapeutics that targets the defective gene behind transthyretin amyloidosis. The results of clinical trials show that the transthyretin gene expression dropped by 96% a month after the new CRISPR-based therapy commenced.
Scope of Report
Attribute
Details
Forecast Period
2014-2021
Historical Data Available for
2022-2029
Market Analysis
Units for Volume and US$ Bn for Value
Key Regions Covered
North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.
Key Countries Covered
United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.
The global gene editing tools market is expected to reach a valuation of US$ 481.3 Mn in 2022.
The global gene editing tools market grew at a healthy 16.2% CAGR between 2014 and 2021.
The increasing demand for synthetic genes and the rising cases of COVID-19 are the key trends boosting the sales of gene editing tools.
Thermo Fisher Scientific, Inc., ERS Genomics, CRISPR Therapeutics, Merck KGaA, Editas Medicine, and GE Healthcare Dharmacon Inc. are some of the leading players present in the global gene editing tools market.
The veterinary medicine segment is anticipated to account for 17.8% of the gene editing tools market share in 2022.
The cell line engineering application segment is projected to account for 41.6% of the gene editing tools market share in the forecast period.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Products Innovation / Key Development Trends
3.3. Product Strategies by Key Manufacturers
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Demand for Animal Productivity, Breeding and Therapeutics
4.3. Demand for Livestock Products
4.4. Advancement in Bioremediation and Waste Management
5. Global Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Expenditure Outlook
6.1.3. R&D Investment Outlook
6.2. Forecast Factors - Relevance & Impact
6.2.1. Increase in R&D Funding and Grants
6.2.2. Increase in Number of Patents Filed
6.2.3. New Product Launches
6.2.4. Investment by Venture Capitalists in Early Stage Biotechs
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Application of in Emerging Areas – Review
7.1. Introduction
7.2. Market Size (US$ Mn) Analysis and Forecast 2022-2029, by Application Area
7.2.1. Veterinary Medicine
7.2.1.1. Animal Therapeutic Products
7.2.1.2. Animal Vaccine Products
7.2.2. Genetic Engineering for Livestock Improvement
7.2.3. Synthetic Biology
7.2.4. Bioremediation
7.2.5. Biosecurity
7.3. Penetration of (%), by Emerging Application Areas
7.3.1. Veterinary Medicine
7.3.2. Genetic Engineering for Livestock Improvement
7.3.3. Synthetic Biology
7.3.4. Bioremediation
7.3.5. Biosecurity
7.4. Penetration of CRISPR (%), by Emerging Application Areas
7.4.1. Veterinary Medicine
7.4.2. Genetic Engineering for Livestock Improvement
7.4.3. Synthetic Biology
7.4.4. Bioremediation
7.4.5. Biosecurity
7.5. Key Trends and Takeaways
8. Global Market Analysis 2014-2021 and Forecast, 2022-2029 By Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 - 2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Gen Editing Type, 2022-2029
8.3.1. Loss of Function
8.3.2. Gain of Function
8.4. Market Attractiveness Analysis By Product Type
9. Global Market Analysis 2014-2021 and Forecast, 2022-2029, by Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2014 - 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2029
9.3.1. Veterinary Medicine
9.3.2. Cell Line Engineering
9.3.3. Bioremediation
9.3.4. Food and Brewing Development
9.3.5. Food Waste Management
9.3.6. Bio sensing Development
9.3.7. Others
9.4. Market Attractiveness Analysis By Application
10. Global Market Analysis 2014-2021 and Forecast, 2022-2029, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By End User, 2014 - 2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2029
10.3.1. Biotech and Pharma Companies
10.3.2. Contract Research Organizations
10.3.3. Academic and Research Institutes
10.3.4. Food Industry
10.3.5. Others
10.4. Market Attractiveness Analysis By End User
11. Global Market Analysis 2014-2021 and Forecast, 2022-2029, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2021
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2029
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. MEA
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2014-2021 and Forecast, 2022-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product Type
12.3.3. By Application Type
12.3.4. By Technology
12.3.5. By End User
12.4. Market Attractiveness Analysis
13. Latin America Market Analysis 2014-2021 and Forecast, 2022-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Rest of Latin America
13.3.2. By Product Type
13.3.3. By Application Type
13.3.4. By Technology
13.3.5. By End User
13.4. Market Attractiveness Analysis
14. Europe Market Analysis 2014-2021 and Forecast, 2022-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product Type
14.3.3. By Application Type
14.3.4. By Technology
14.3.5. By End User
14.4. Market Attractiveness Analysis
15. East Asia Market Analysis 2014-2021 and Forecast, 2022-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
15.3.1. By Country
15.3.1.1. C China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product Type
15.3.3. By Application Type
15.3.4. By Technology
15.3.5. By End User
15.4. Market Attractiveness Analysis
16. South Asia Analysis 2014-2021 and Forecast, 2022-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product Type
16.3.3. By Application Type
16.3.4. By Technology
16.3.5. By End User
16.4. Market Attractiveness Analysis
17. Oceania Market Analysis 2014-2021 and Forecast, 2022-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product Type
17.3.3. By Application Type
17.3.4. By Technology
17.3.5. By End User
17.4. Market Attractiveness Analysis
18. Middle East and Africa Market Analysis 2014-2021 and Forecast, 2022-2029
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. Northern Africa
18.3.1.4. South Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product Type
18.3.3. By Application Type
18.3.4. By Technology
18.3.5. By End User
18.4. Market Attractiveness Analysis
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Deep Dive
20.2.1. Thermo Fisher Scientific, Inc.
20.2.1.1. Overview
20.2.1.2. Product Portfolio
20.2.1.3. Sales Footprint
20.2.1.4. Analysis Commentary
20.2.2. ERS Genomics
20.2.3. CRISPR THERAPEUTICS
20.2.4. Merck KGaA
20.2.5. Editas Medicine
20.2.6. GE Healthcare Dharmacon Inc.
20.2.7. Takara Bio USA
20.2.8. New England Biolabs
20.2.9. Horizon Discovery Group plc
20.2.10. Intellia Therapeutics, Inc.
20.2.11. GenScript Biotech Corporation
21. Assumptions and Acronyms Used22. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Key Company and Product Mapping
Table 02: Estimates of Funding Offered by NIH for Various Research, Condition, and Disease Categories (RCDC), 2015-2022
Table 03: Estimates of Funding Offered by NIH for Various Research, Condition, and Disease Categories (RCDC), 2015-2022
Table 04: Estimates of Funding Offered by NIH for Various Research, Condition, and Disease Categories (RCDC), 2015-2022
Table 05: Estimates of Funding Offered by NIH for Various Research, Condition, and Disease Categories (RCDC), 2015-2022
Table 06: Estimated Number of Deaths for the Four Major Cancers by Sex and Age Group, 2017
Table 07: Estimated Volume for Beef and Veal Production - by Region and Countries, 2017
Table 08: Estimated Volume for Beef and Veal Consumption - by Region and Countries, 2017
Table 09: Estimated Volume for Cattle Stocks (in 1,000 head) - by Region and Countries, 2017
Table 10: Estimated Volume for Production (Calf Crop) - by Region and Countries, 2017
Table 11: Estimated Volume for Pork Production - by Region and Countries, 2017
Table 12: Estimated Volume for Pork Consumption - by Region and Countries, 2017
Table 13: Estimated Volume for Swine Stocks (in 1,000 head) - by Region and Countries, 2017
Table 14: Estimated Volume for Production (Pig Crop) - by Region and Countries, 2017
Table 15: Estimated Volume for Chicken Stocks (in 1,000 head) - by Region and Countries, 2017
Table 16: Global Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Product Type
Table 17: Global Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Application
Table 18: Global Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By End User
Table 19: Global Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Region
Table 20: North America Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Country
Table 21: North America Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Product Type
Table 22: North America Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Application
Table 23: North America Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By End User
Table 24: Latin America Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Country
Table 25: Latin America Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Product Type
Table 26: Latin America Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Application
Table 27: Latin America Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By End User
Table 28: Europe Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Country
Table 29: Europe Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Product Type
Table 30: Europe Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Application
Table 31: Europe Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By End User
Table 32: East Asia Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Country
Table 33: East Asia Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Product Type
Table 34: East Asia Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Application
Table 35: East Asia Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By End User
Table 36: South Asia Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Country
Table 37: South Asia Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Product Type
Table 38: South Asia Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Application
Table 39: South Asia Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By End User
Table 40: Oceania Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Country
Table 41: Oceania Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Product Type
Table 42: Oceania Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Application
Table 43: Oceania Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By End User
Table 44: MEA Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Country
Table 45: MEA Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Product Type
Table 46: MEA Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By Application
Table 47: MEA Market size (US$ Mn) Analysis 2014–2021 and forecast 2022–2029, By End User
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: CRISPR-Based Gene Editing Kits (US$), By Region (2017)
Figure 02: Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2014–2029
Figure 03: Global Market Absolute $ Opportunity (US$ Mn), 2021–2029
Figure 04: Exponential Increase in CRISPR-related U.S. patent Filings, Number of Patents Filed and Published Applications
Figure 05: Global Number of Patents and Other Intellectual Properties Associated with CRISPR Gene Editing, Acquired by Companies & Universities, 2021
Figure 06: Penetration of (%), by Emerging Application Areas
Figure 07: Global Market Share Analysis (%) By Product Type, 2022 & 2029
Figure 08: Global Market Y-o-Y Growth (%) By Product Type, 2022–2029
Figure 09: Global Market Value, 2014–2021, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 10: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 11: Global Market Value, 2014–2021, Zinc Finger Nucleases (ZFNs)
Figure 12: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Zinc Finger Nucleases (ZFNs)
Figure 13: Global Market Value, 2014–2021, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 14: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 15: Global Market Value, 2014–2021, Viral Systems
Figure 16: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Viral Systems
Figure 17: Global Market Value, 2014–2021, Transposon Systems
Figure 18: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transposon Systems
Figure 19: Global Market Value, 2014–2021, Others
Figure 20: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Others
Figure 21: Global Market Attractiveness Analysis By Product Type, 2022–2029
Figure 22: Global Market Share Analysis (%) By Application, 2022 & 2029
Figure 23: Global Market Y-o-Y Growth (%) By Application, 2022–2029
Figure 24: Global Market Value, 2014–2021, Veterinary Medicine
Figure 25: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Veterinary Medicine
Figure 26: Global Market Value, 2014–2021, Cell Line Engineering
Figure 27: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Cell Line Engineering
Figure 28: Global Market Value, 2014–2021, Bioremediation
Figure 29: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Bioremediation
Figure 30: Global Market Value, 2014–2021, Food and Brewing Development
Figure 31: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Food and Brewing Development
Figure 32: Global Market Value, 2014–2021, Food Waste Management
Figure 33: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Food Waste Management
Figure 34: Global Market Value, 2014–2021, Bio Sensing Development
Figure 35: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Bio Sensing Development
Figure 36: Global Market Value, 2014–2021, Others
Figure 37: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Others
Figure 38: Global Market Attractiveness Analysis By Application, 2022–2029
Figure 39: Global Market Share Analysis (%) By End User, 2022 & 2029
Figure 40: Global Market Y-o-Y Growth (%) By End User, 2022–2029
Figure 41: Global Market Value, 2014–2021, Biotech and Pharma Companies
Figure 42: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Biotech and Pharma Companies
Figure 43: Global Market Value, 2014–2021, Contract Research Organizations
Figure 44: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Contract Research Organizations
Figure 45: Global Market Value, 2014–2021, Academic and Research Institutes
Figure 46: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Academic and Research Institutes
Figure 47: Global Market Value, 2014–2021, Food Industry
Figure 48: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Food Industry
Figure 49: Global Market Value, 2014–2021, Others
Figure 50: Global Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Others
Figure 51: Global Market Attractiveness Analysis By End User, 2022–2029
Figure 52: Global Market Share Analysis (%) By Region, 2022 & 2029
Figure 53: Global Market Y-o-Y Growth (%) By Region, 2022–2029
Figure 54: Global Market Attractiveness Analysis By Region, 2022–2029
Figure 55: North America Market, by Product Type (2021)
Figure 56: North America Market, Snapshot
Figure 57: North America Market, by Application (2021)
Figure 58: North America Market, by Country (2021)
Figure 59: North America Market, by End User (2021)
Figure 60: North America Market Size (US$ Mn) Analysis, 2014–2021
Figure 61: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029
Figure 62: North America Market Value, 2014–2021, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 63: North America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 64: North America Market Value, 2014–2021, Zinc Finger Nucleases (ZFNs)
Figure 65: North America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Zinc Finger Nucleases (ZFNs)
Figure 66: North America Market Value, 2014–2021, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 67: North America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 68: North America Market Value, 2014–2021, Viral Systems
Figure 69: North America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Viral Systems
Figure 70: North America Market Value, 2014–2021, Transposon Systems
Figure 71: North America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transposon Systems
Figure 72: North America Market Value, 2014–2021, Others
Figure 73: North America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Others
Figure 74: North America Market Attractiveness Analysis, By Country (2022-2029)
Figure 75: North America Market Attractiveness Analysis, By Product Type (2022-2029)
Figure 76: North America Market Attractiveness Analysis, By Application (2022-2029)
Figure 77: North America Market Attractiveness Analysis, By End User (2022-2029)
Figure 78: Latin America Market, by Product Type (2021)
Figure 79: Latin America Market, Snapshot
Figure 80: Latin America Market, by Application (2021)
Figure 81: Latin America Market, by Country (2021)
Figure 82: Latin America Market, by End User (2021)
Figure 83: Latin America Market Size (US$ Mn) Analysis, 2014–2021
Figure 84: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029
Figure 85: Latin America Market Value, 2014–2021, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 86: Latin America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 87: Latin America Market Value, 2014–2021, Zinc Finger Nucleases (ZFNs)
Figure 88: Latin America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Zinc Finger Nucleases (ZFNs)
Figure 89: Latin America Market Value, 2014–2021, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 90: Latin America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 91: Latin America Market Value, 2014–2021, Viral Systems
Figure 92: Latin America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Viral Systems
Figure 93: Latin America Market Value, 2014–2021, Transposon Systems
Figure 94: Latin America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transposon Systems
Figure 95: Latin America Market Value, 2014–2021, Others
Figure 96: Latin America Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Others
Figure 97: Latin America Market Attractiveness Analysis, By Country (2022-2029)
Figure 98: Latin America Market Attractiveness Analysis, By Product Type (2022-2029)
Figure 99: Latin America Market Attractiveness Analysis, By Application (2022-2029)
Figure 100: Latin America Market Attractiveness Analysis, By End User (2022-2029)
Figure 101: Europe Market, by Product Type (2021)
Figure 102: Europe Market, Snapshot
Figure 103: Europe Market, by Application (2021)
Figure 104: Europe Market, by Country (2021)
Figure 105: Europe Market, by End User (2021)
Figure 106: Europe Market Size (US$ Mn) Analysis, 2014–2021
Figure 107: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029
Figure 108: Europe Market Value, 2014–2021, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 109: Europe Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 110: Europe Market Value, 2014–2021, Zinc Finger Nucleases (ZFNs)
Figure 111: Europe Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Zinc Finger Nucleases (ZFNs)
Figure 112: Europe Market Value, 2014–2021, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 113: Europe Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 114: Europe Market Value, 2014–2021, Viral Systems
Figure 115: Europe Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Viral Systems
Figure 116: Europe Market Value, 2014–2021, Transposon Systems
Figure 117: Europe Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transposon Systems
Figure 118: Europe Market Value, 2014–2021, Others
Figure 119: Europe Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Others
Figure 120: Europe Market Attractiveness Analysis, By Country (2022-2029)
Figure 121: Europe Market Attractiveness Analysis, By Product Type (2022-2029)
Figure 122: Europe Market Attractiveness Analysis, By Application (2022-2029)
Figure 123: Europe Market Attractiveness Analysis, By End User (2022-2029)
Figure 124: East Asia Market, by Product Type (2021)
Figure 125: East Asia Market, Snapshot
Figure 126: East Asia Market, by Application (2021)
Figure 127: East Asia Market, by Country (2021) and (2029)
Figure 128: East Asia Market, by End User (2021)
Figure 129: East Asia Market Size (US$ Mn) Analysis, 2014–2021
Figure 130: East Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029
Figure 131: East Asia Market Value, 2014–2021, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 132: East Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 133: East Asia Market Value, 2014–2021, Zinc Finger Nucleases (ZFNs)
Figure 134: East Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Zinc Finger Nucleases (ZFNs)
Figure 135: East Asia Market Value, 2014–2021, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 136: East Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 137: East Asia Market Value, 2014–2021, Viral Systems
Figure 138: East Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Viral Systems
Figure 139: East Asia Market Value, 2014–2021, Transposon Systems
Figure 140: East Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transposon Systems
Figure 141: East Asia Market Value, 2014–2021, Others
Figure 142: East Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Others
Figure 143: East Asia Market Attractiveness Analysis, By Country (2022-2029)
Figure 144: East Asia Market Attractiveness Analysis, By Product Type (2022-2029)
Figure 145: East Asia Market Attractiveness Analysis, By Application (2022-2029)
Figure 146: East Asia Market Attractiveness Analysis, By End User (2022-2029)
Figure 147: South Asia Market, by Product Type (2021)
Figure 148: South Asia Market, Snapshot
Figure 149: South Asia Market, by Application (2021)
Figure 150: South Asia Market, by Country (2021) and (2029)
Figure 151: South Asia Market, by End User (2021)
Figure 152: South Asia Market Size (US$ Mn) Analysis, 2014–2021
Figure 153: South Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029
Figure 154: South Asia Market Value, 2014–2021, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 155: South Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 156: South Asia Market Value, 2014–2021, Zinc Finger Nucleases (ZFNs)
Figure 157: South Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Zinc Finger Nucleases (ZFNs)
Figure 158: South Asia Market Value, 2014–2021, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 159: South Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 160: South Asia Market Value, 2014–2021, Viral Systems
Figure 161: South Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Viral Systems
Figure 162: South Asia Market Value, 2014–2021, Transposon Systems
Figure 163: South Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transposon Systems
Figure 164: South Asia Market Value, 2014–2021, Others
Figure 165: South Asia Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Others
Figure 166: South Asia Market Attractiveness Analysis, By Country (2022-2029)
Figure 167: South Asia Market Attractiveness Analysis, By Product Type (2022-2029)
Figure 168: South Asia Market Attractiveness Analysis, By Application (2022-2029)
Figure 169: South Asia Market Attractiveness Analysis, By End User (2022-2029)
Figure 170: Oceania Market, by Product Type (2021)
Figure 171: Oceania Market, Snapshot
Figure 172: Oceania Market, by Application (2021)
Figure 173: Oceania Market, by Country (2021) and (2029)
Figure 174: Oceania Market, by End User (2021)
Figure 175: Oceania Market Size (US$ Mn) Analysis, 2014–2021
Figure 176: Oceania Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029
Figure 177: Oceania Market Value, 2014–2021, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 178: Oceania Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 179: Oceania Market Value, 2014–2021, Zinc Finger Nucleases (ZFNs)
Figure 180: Oceania Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Zinc Finger Nucleases (ZFNs)
Figure 181: Oceania Market Value, 2014–2021, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 182: Oceania Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 183: Oceania Market Value, 2014–2021, Viral Systems
Figure 184: Oceania Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Viral Systems
Figure 185: Oceania Market Value, 2014–2021, Transposon Systems
Figure 186: Oceania Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transposon Systems
Figure 187: Oceania Market Value, 2014–2021, Others
Figure 188: Oceania Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Others
Figure 189: Oceania Market Attractiveness Analysis, By Country (2022-2029)
Figure 190: Oceania Market Attractiveness Analysis, By Product Type (2022-2029)
Figure 191: Oceania Market Attractiveness Analysis, By Application (2022-2029)
Figure 192: Oceania Market Attractiveness Analysis, By End User (2022-2029)
Figure 193: MEA Market, by Product Type (2021)
Figure 194: MEA Market, Snapshot
Figure 195: MEA Market, by Application (2021)
Figure 196: MEA Market, by Country (2021) and (2029)
Figure 197: MEA Market, by End User (2021)
Figure 198: Oceania Market Size (US$ Mn) Analysis, MEA
Figure 199: MEA Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029
Figure 200: MEA Market Value, 2014–2021, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 201: MEA Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
Figure 202: MEA Market Value, 2014–2021, Zinc Finger Nucleases (ZFNs)
Figure 203: MEA Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Zinc Finger Nucleases (ZFNs)
Figure 204: MEA Market Value, 2014–2021, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 205: MEA Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transcription Activator-Like Effector Nucleases (TALENs)
Figure 206: MEA Market Value, 2014–2021, Viral Systems
Figure 207: MEA Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Viral Systems
Figure 208: MEA Market Value, 2014–2021, Transposon Systems
Figure 209: MEA Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Transposon Systems
Figure 210: MEA Market Value, 2014–2021, Others
Figure 211: MEA Market Value, Forecast & Y-o-Y Growth (%), 2022–2029, Others
Figure 212: MEA Market Attractiveness Analysis, By Country (2022-2029)
Figure 213: MEA Market Attractiveness Analysis, By Product Type (2022-2029)
Figure 214: MEA Market Attractiveness Analysis, By Application (2022-2029)
Figure 215: MEA Market Attractiveness Analysis, By End User (2022-2029)
